OpenHealth Company

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

OpenHealth Company - overview

Established

2000

Location

Paris, -, France

Primary Industry

Software

About

Based in Vannes, France, and founded in 2000, OpenHealth Company formerly known as Celtipharm operates as a pharmaceutical data company. In July 2015, Celtipharm with its offices in Vannes and Paris, as well as its subsidiaries Carré Castan Consultants and Medext Group brought together to create OpenHealth Company. Some of the firm’s clients are Leje Perrigo, BioNutrics, CCD, etc. OpenHealth as of May 2023, the firm is led by its CEO, Nicolas Grélaud.


The company collects processes, enhances, and analyses health data for health authorities, industry researchers, and the general public. The list of products and solutions offered by the firm are consumer data and analytics for improving clients’ marketing and sales efficiency, patient data and analytics for making data available from real-world evidence, and the daily life of patients. OpenHealth also offers a data processing model, to support its institutional and healthcare clients to enhance their data by building a platform by integrating their own data.


Current Investors

Institut de Participations de l'Ouest, Ouest Croissance, Avenir Entreprises

Primary Industry

Software

Sub Industries

Analytics & Performance Software, Application Integration Software

Website

www.openhealth.fr

Verticals

Big Data, HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

OpenHealth Company - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

OpenHealth Company - financials

Fiscal Year EndedDec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Revenue (USD)8,217,8287,178,6596,870,1036,599,2075,875,7886,734,291---
% Revenue Growth (YoY)-(12.6%)(4.3%)(3.9%)(11.0%)14.6%---
EBITDA (USD)(1,243,952)(2,867,300)(1,446,847)(612,754)(70,695)576,157---
Operating Income (USD)(1,731,726)(3,430,991)(2,358,936)(1,688,592)(980,202)(174,745)---
Operating Margin(21.1%)(47.8%)(34.3%)(25.6%)(16.7%)(2.6%)---
% EBITDA Margin(15.1%)(39.9%)(21.1%)(9.3%)(1.2%)8.6%---
NET Income (USD)(1,246,378)(2,731,655)(1,860,693)(1,034,697)(571,243)243,594---
% Net Margin(15.2%)(38.1%)(27.1%)(15.7%)(9.7%)3.6%---

OpenHealth Company - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.